期刊文献+

影响地高辛血药浓度的因素分析 被引量:10

Analysis of factors influencing serum digoxin concentration
在线阅读 下载PDF
导出
摘要 目的调查分析地高辛血药浓度的影响因素,为合理用药提供参考。方法通过Cnki、PubMed数据库中检索近年来地高辛相关文献并整理分析。结果性别、年龄、生理病理状态、剂型、药物的相互作用是影响地高辛血药浓度的重要因素。大环内酯类抗生素、硝苯地平、维拉帕米、缬沙坦、胺碘酮、利托那韦、质子泵抑制剂等可导致地高辛血药浓度显著提高。硝普钠、甲氧氯普安、莫沙必利、氢氧化铝、药用炭等可导致地高辛血药浓度显著降低。结论临床医师或药师在设计给药方案时,应结合患者的生理病理状况,结合临床表现和联合用药等因素综合评价地高辛的疗效,合理制定个性化给药方案,以达到最佳治疗效果,降低不良反应的发生。 Objective To investigate the factors for plasma concentration of digoxin, provide a reference for the rational use of medicines. Methods Retriecaled the related articles of digoxin by Cnki, PubMed,Web of Science database to retrieve and analyze. Results Gender, age, different disease states, different dosage forms and drug interactions can affect serum digoxin concentration, macrolides, amiodarone, and ritonavir can lead to serum digoxin concentrations were significantly increased. Proton pump inhibitor omeprazole significantly increased gastric pH value, inhibit gastric acid destruction of digoxin, the digoxin bioavailability increased. Aluminum hydroxide, aluminum hydroxide compound, such as to make medicinal charcoal to reduce absorption of digoxin, the serum concentration decreased. Conclusion Clinicians or pharmacists in the design of dosing regimens, in combination with the patient's physiological and pathological conditions and drug interactions, a comprehensive consideration of various factors on the serum digoxin concentration in order to better play digoxin treatment, thereby reducing mortality, readmission rates and the incidence of poisoning.
出处 《中国医药科学》 2012年第19期33-35,共3页 China Medicine And Pharmacy
基金 河南省科技厅资助项目(072103810601)
关键词 地高辛 血药浓度监测 影响因素 药物相互作用 合理用药 Digoxin Therapeutic drug monitoring Influence factors Drug interactions Rational use of drug
  • 相关文献

参考文献19

  • 1Rengelshausen J, Goggelmann C, Burhenne J, et al.Conlribution of increased oral bioavailahility and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction[J].Br J Clin Pharmacol, 2003,56 (1): 32-38.
  • 2Tanaka H, MatsumotoK, Ueno K, et al.Effect of clarithromycin on steady-state digoxin concentrations [J].Ann Pharmacot her, 2003,37 ( 2 ) : 178-181.
  • 3Cambonic G, Sabatier E, Guillaumont S, at al.Digoxin-josamycin: a dangerous drug interaction in children[J]. ArchPediatr, 2006, 13 ( 8 ) : 1118-1120.
  • 4Nenciu LM, Laberge P, Thirion DJ.Telithromycin-induced digoxin toxicity and electrocardiographic changes [J].Phamacotherapy, 2006,26 ( 6 ) : 872-876.
  • 5Penzak SR, Shen JM, Alfaro RM, et al.Ritonavir decreases the nonrcnal clearance of digoxin in healthy volunteers with known MDR 1 gcnotypcs[J].ThcrDrug Monit,2004,26 ( 3 ): 322-330.
  • 6黄守坚,陈汝筑,黎明涛.地高辛的个体化用药[J].新医学,2004,35(3):177-179. 被引量:10
  • 7赵瑞祥.地高辛药学监护和药物相互作用[J].中国疗养医学,2004,13(5):264-265. 被引量:4
  • 8田红军.地高辛联合用药的相互作用[J].中国自然医学杂志,2003,5(2):99-99. 被引量:5
  • 9陈世铭.药物不良相互作用的临床意义与处理[J].北京:中国科学技术出版社,1981:58.
  • 10Bachmakov I, Werner U, Endress B, et al.Characterizatinn of betaadrenoceptor antagonists as subst rates and inhibitnrs of the drug transporter P-glycoprotein[J].Fundam Clin Pharmacol, 2006,20 ( 3 ) : 273-282.

二级参考文献17

  • 1[4]Wolin MJ. Digoxin visual toxicity with therapeutic blood levels of digoxin. Am J Ophthalmol, 1998, 125(3): 406.
  • 2[5]王海燕.肾脏病学.第2版.北京:人民卫生出版社,1998.1034-1038.
  • 3[1]The digitals investcgation Group.The effect of digoxin on mortality and morbility in patients with heart failure.N EngL J Med,1997,336:525-533.
  • 4何厚琦,蒋贤.地高辛维持量疗法是降低洋地黄中毒发生率的较佳方法[J].中国急救医学,1984,(4):198.
  • 5[3]Farghi R.Ventricular rate Lontral in chronic atrial fibrillation during daily activity and programmed exercise:a crossover opne-Label study of five drug regimens.J Am coll cardiol,1999,33:304-310.
  • 6李家泰.临床药理学[M],第二版[M].北京:人民卫生出版社,1998.914-921,1199,493.
  • 7Pall Walsh. Physicians'desk refrence[M]. America,Medical Ecmomics Company,2003. 1003
  • 8Tanaka H Matsumoto K, Ueno K, et al. Effect of clarithromycin onsteady - state degoxin concentrations [J].AnnPharmacot her, 2003,37 ( 2 ): 178
  • 9Carroll J.A,SeelyEW,Tao QF,et a1. Digitalis-like factor response to hyperinsulinemia accompanying a euglycemic hyperinsulinernic clamp or lral glucose tolerance test[J],Life Sci,2001,69(7):829
  • 10The Digitalis Investigation Group.The effect of digoxin on mortality and morbidity in patients with heart failure[J].N Engl J Med,1997,336(8):525-533.

共引文献29

同被引文献82

引证文献10

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部